Jell Pharmaceuticals Private Limited, a active private limited company, was established on 31 August 1994 in Mumbai, Maharashtra, India. Engaging in home care & cleaning products within the manufacturing sector, it holds CIN: U23200MH1994PTC080671. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Employing 222 professional, Its leadership includes Sanjay Chandrakant Mehta (Whole-Time Director), Chirag Chandrakant Mehta (Whole-Time Director). Past directors included Sanjay Chandrakant Mehta, Parag Chandrakant Mehta, Chirag Chandrakant Mehta. It holds ₹67.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B-6/A, Sidhapura Industrial Estate, L.B. Shastri Marg, Ghatkopar (W),, Mumbai, Maharashtra, 400086.
U23200MH1994PTC080671
080671
31 August 1994
₹1.00 Cr
₹1.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Jell Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Chandrakant Mehta | Whole-Time Director | 31 Aug 1994 | Current |
| Chirag Chandrakant Mehta | Whole-Time Director | 31 Aug 1994 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Nov 2018 | Past |
| Pramod Abcsdd | Director | 22 Nov 2018 | Past |
| Pramod Abcsdd | Director | 22 Nov 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jell Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.45% increase. The company also saw a slight decrease in profitability, with a 5.67% decrease in profit. The company's net worth Soared by an impressive increase of 18.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Jell Pharmaceuticals had a promoter holding of 31.35% and a public holding of 68.65%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹675,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jul 2024 | Others | ₹1.00 Cr | Open |
| 14 Dec 2011 | Bank Of India | ₹3.00 Cr | Open |
| 25 Jan 2007 | Bank Of India | ₹63.50 Cr | Open |
Explore comprehensive loan charge details -
Jell Pharmaceuticals has a workforce of 222 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Jell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jell Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Bank Of India of Rs. 63.50 Cr registered on 25 Jan 2007 with Charge ID 10036129 was modified on 04 Feb 2025. was documented.
The activity Jell Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100955857 was registered on 09 Jul 2024. was completed.
The activity Jell Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity A charge with Bank Of India amounted to Rs. 3.00 Cr with Charge ID 10328576 was registered on 14 Dec 2011. was completed.
The activity A charge with Bank Of India amounted to Rs. 63.50 Cr with Charge ID 10036129 was registered on 25 Jan 2007. was completed.
The CIN of Jell Pharmaceuticals Private Limited is U23200MH1994PTC080671.
Jell Pharmaceuticals Private Limited is headquartered at B-6/A, Sidhapura Industrial Estate, L.B. Shastri Marg, Ghatkopar (W),, Mumbai, Maharashtra, 400086.
Jell Pharmaceuticals Private Limited was incorporated on 31 August 1994.
The current directors of Jell Pharmaceuticals Private Limited are
The primary industry of Jell Pharmaceuticals Private Limited is Manufacturing.
Jell Pharmaceuticals Private Limited is unlisted.
The authorized capital of Jell Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Jell Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX